Imported Sputnik V to be available this quarter: Dr. Reddy’s
The Hindu
Contract is for 250 million vaccine units which is extendable, says pharma major
A day after , marketing partner for the Russian COVID-19 vaccine Dr. Reddy’s Laboratories said the imported product will be available in the country by this quarter. It will start this quarter, via the imported route and the availability will be ramped up next quarter once the Made in India Sputnik V comes on stream. Discussions with the government and other stakeholders on pricing are under way, the Hyderabad-based pharma major’s senior leadership said on Wednesday. The contract with Russian Direct Investment Fund (RDIF), which has partnered Dr. Reddy’s for clinical trials and distribution, is 250 million vaccine units (125 million people doses). This number is extendable, CEO of API and Services business Deepak Sapra said.More Related News